Centene (NYSE:CNC – Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Tuesday, October 27th. Analysts expect the company to announce earnings of $0.0958 per share and revenue of $47.12 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 8:30 AM ET.
Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings results on Monday, July 27th. The company reported $2.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $1.42. The company had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.16) earnings per share. On average, analysts expect Centene to post $4.89 EPS for the current fiscal year and $5.34 EPS for the next fiscal year.
Centene Stock Up 0.0%
Centene stock opened at $70.20 on Monday. The company has a 50-day simple moving average of $65.79 and a 200-day simple moving average of $61.13. The firm has a market capitalization of $34.68 billion, a P/E ratio of -6.72, a P/E/G ratio of 0.44 and a beta of 1.13. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. Centene has a one year low of $31.63 and a one year high of $72.50.
Insider Activity at Centene
In other news, General Counsel Christopher Koster sold 56,500 shares of the stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the completion of the sale, the general counsel owned 248,854 shares in the company, valued at approximately $16,648,332.60. This represents a 18.50% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.37% of the company’s stock.
Analyst Ratings Changes
CNC has been the subject of a number of analyst reports. Barclays reissued an “overweight” rating and set a $80.00 target price (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. TD Cowen restated a “hold” rating and issued a $65.00 price target (up from $47.00) on shares of Centene in a research note on Tuesday, July 14th. Argus upgraded shares of Centene from a “hold” rating to a “buy” rating and set a $80.00 price target on the stock in a research note on Tuesday, August 11th. Zacks Research downgraded shares of Centene from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Centene in a research note on Friday, October 9th. Nine equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $70.05.
Get Our Latest Stock Report on CNC
About Centene
Centene Corporation is a diversified healthcare enterprise that provides government-sponsored and commercial health insurance programs and related healthcare services. The company’s offerings are primarily focused on Medicaid, Medicare, and health insurance marketplace plans, with an emphasis on serving individuals and families who may have limited access to traditional healthcare coverage.
Centene operates Medicaid health plans through state-based contracts and offers Medicare Advantage, Medicare prescription drug, and Medicare Supplement products through its Wellcare brand.
Featured Stories
- Five stocks we like better than Centene
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
